Research and Development

US Biotech firm Metamark Genetics has named the former general manager of HealthTronics Laboratory Solutions Cornelius Merlini, as its senior …

Researchers have discovered a simple method of producing mice stem cells that could mark a new era of regenerative medicine.  …

Dr Todd Hobbs has been appointed chief medical officer (CMO) for Novo Nordisk in North America.   In this role …

The FDA has approved a high-dose version of Teva’s multiple sclerosis drug Copaxone which will help the firm offset approaching …

Merck KGaA’s chief financial officer Matthias Zachert is exiting the firm in order to fulfill a chief executive appointment at …

Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …

An experimental cancer drug developed by Pfizer has failed in two separate Phase III clinical studies. Dacomitinib is a tyrosine …

Clinical-stage biopharma firm Targecept has appointed its non-executive director since 2002 John Richard to be its chairman of the board. …

Some nine months after the coalition government’s controversial health reforms came in, have they been a success? And how are …

Biopharma firm PTC Therapeutics has expanded its senior management team with a raft of appointments. Robert Spiegel (pictured) becomes its …

Clinical trials services firm Biotec Services International is looking to expand its presence in the US with the appointment of …

A new report has found that Johnson & Johnson is the most engaged pharma company when it comes to using …

Comms and PR consulting firm Hanover has announced senior management changes within its healthcare practice. Andrew Harrison (pictured) takes on …

Biocon has said its generic version of Roche’s ageing breast cancer drug Herceptin will go on sale in India from …